Showing results (1-10 of 8) with videos related to
Sort By:
Pageof 1
Journal of Neuroscience Research|May 22, 2020
Sex-dimorphic effects of biogenesis of lysosome-related organelles complex-1 deficiency on mouse perinatal brain developmentFrank Y Lee, Jennifer Larimore, Victor Faundez, et al.Bio-Protocol|June 17, 2026
Histomorphometrical Analyses of the Mouse Suprachiasmatic NucleusSophia A M B Villanueva, Frank Y Lee, Olivia N Hitchcock, et al.Journal of Magnetic Resonance Imaging : JMRI|February 16, 2012
Liver fibrosis: an intravoxel incoherent motion (IVIM) studyApril M Chow, Darwin S Gao, Shu Juan Fan, et al.Journal of Magnetic Resonance Imaging : JMRI|February 16, 2012
Measurement of liver T₁ and T₂ relaxation times in an experimental mouse model of liver fibrosisApril M Chow, Darwin S Gao, Shu Juan Fan, et al.NMR in Biomedicine|February 19, 2013
Bilateral substantia nigra and pyramidal tract changes following experimental intracerebral hemorrhage: an MR diffusion tensor imaging studyShu-Juan Fan, Frank Y Lee, Matthew M Cheung, et al.Frontiers in Neuroscience|December 1, 2018
Sleep/Wake Disruption in a Mouse Model of BLOC-1 DeficiencyFrank Y Lee, Huei-Bin Wang, Olivia N Hitchcock, et al.Journal of Medicinal Chemistry|March 19, 2004
Design and synthesis of a fluoroindolocarbazole series as selective topoisomerase I active agents. Discovery of water-soluble 3,9-difluoro-12,13-dihydro-13-[6-amino-beta-D-glucopyranosyl]-5H,13H-benzo[b]- thienyl[2,3-a]pyrrolo[3,4-c]carbazole- 5,7(6H)-dione (BMS-251873) with curative antitumor activity against prostate carcinoma xenograft tumor modelBalu N Balasubramanian, Denis R St Laurent, Mark G Saulnier, et al.Journal of Medicinal Chemistry|April 2, 2005
Discovery of a fluoroindolo[2,3-a]carbazole clinical candidate with broad spectrum antitumor activity in preclinical tumor models superior to the marketed oncology drug, CPT-11Mark G Saulnier, Balu N Balasubramanian, Byron H Long, et al.Pageof 1